Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: a cross‐sectional study

D Gagliardi, I Faravelli, M Meneri… - Journal of Cellular …, 2021 - Wiley Online Library
Motor neuron disease (MND) is a rare group of disorders characterized by degeneration of
motor neurons (MNs). The most common form of MND, amyotrophic lateral sclerosis (ALS) …

Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature

D Gagliardi, M Meneri, D Saccomanno… - International journal of …, 2019 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting upper
and lower motor neurons (MNs) that still lacks an efficacious therapy. The failure of recent …

Neurofilaments in CSF as diagnostic biomarkers in motor neuron disease: a meta-analysis

D Li, D Shen, H Tai, L Cui - Frontiers in aging neuroscience, 2016 - frontiersin.org
Objective: Neurofilaments in CSF are promising biomarkers which might help in the
diagnosis of motor neuron disease (MND). We aim to assess the diagnostic value of …

CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis

D Rossi, P Volanti, L Brambilla, T Colletti, R Spataro… - Journal of …, 2018 - Springer
Elevated cerebrospinal fluid (CSF), Neurofilament Light (NF-L) and phosphorylated Heavy
(pNF-H) chain levels have been found in Amyotrophic Lateral Sclerosis (ALS), with studies …

Diagnostic and prognostic performance of neurofilaments in ALS

K Poesen, P Van Damme - Frontiers in neurology, 2019 - frontiersin.org
There is a need for biomarkers for amyotrophic lateral sclerosis (ALS), to support the
diagnosis of the disease, to predict disease progression and to track disease activity and …

Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis

I Heckler, I Venkataraman - Journal of Neurophysiology, 2022 - journals.physiology.org
Neuroaxonal damage is a feature of various neurodegenerative diseases including
amyotrophic lateral sclerosis (ALS). Phosphorylated neurofilament heavy chain (pNfH) is a …

Serum neurofilaments in motor neuron disease and their utility in differentiating ALS, PMA and PLS

G McCluskey, KE Morrison, C Donaghy, J McConville… - Life, 2023 - mdpi.com
Neurofilament levels are elevated in many neurodegenerative diseases and have shown
promise as diagnostic and prognostic biomarkers in Amyotrophic Lateral Sclerosis (ALS) …

Neurofilaments as biomarkers for amyotrophic lateral sclerosis: a systematic review and meta-analysis

Z Xu, RD Henderson, M David, PA McCombe - PLoS One, 2016 - journals.plos.org
Background To allow early diagnosis and monitoring of disease progression, there is a need
for biomarkers in amyotrophic lateral sclerosis (ALS). Neurofilaments (NF) are emerging …

CSF neurofilament light chain levels in primary progressive MS: signs of axonal neurodegeneration

M Pawlitzki, S Schreiber, D Bittner, J Kreipe… - Frontiers in …, 2018 - frontiersin.org
Objectives: Elevated neurofilament light chain (NFL) levels within the cerebrospinal fluid
(CSF) are a biomarker representing axonal neurodegeneration in rapid progressive …

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

J Shi, X Qin, X Chang, H Wang, J Guo… - Journal of Cellular and …, 2022 - Wiley Online Library
This study aims to determine the serum and cerebrospinal fluid (CSF) levels of
neurofilament light chain (NFL) and phosphorylated neurofilament heavy chain (pNFH) in …